3 results on '"Logowska, I."'
Number of results to display per page
Search Results
2. Best practices for the management of local-regional recurrent chordoma: a position paper by the Chordoma Global Consensus Group
- Author
-
Stacchiotti, Silvia, Gronchi, Alesandro, Fossati, P., Akiyama, T., Alapetite, C., Baumann, M., Blay, Jean-Yves, Bolle, S., Boriani, S., Bruzzi, Paolo, Capanna, R., Caraceni, A., Casadei, R., Colia, V., Debus, Jürgen, Delaney, T., Dileo, P., Dijkstra, S., Doglietto, F., Flanagan, Adrienne, Froelich, S., Gardner, Paul A., Gelderblom, Hans, Gokaslan, Z. L., Haas, R. L., Heery, C., Hindi, Nadia, Hohenberger, Peter, Hornicek, F., Imai, R., Jeys, L., Jones, Robin L., Kasper, Bernd, Kawai, Akira, Krengli, M., Leithner, Andreas, Logowska, I., Martín-Broto, Javier, Mazzatenta, D., Morosi, Carlo, Nicolai, P., Norum, O. J., Patel, S., Penel, Nicolas, Picci, Piero, Pilotti, S., Radaelli, Stefano, Ricchini, F., Rutkowski, Piotr, Scheipl, S., Sen, C., Tamborini, E., Thornton, K. A., Timmermann, B., Torri, V., Tunn, P. U., Uhl, Matthias, Yamada, Y., Weber, D. C., Vanel, D., Varga, P. P., Vleggeert-Lankamp, C. L. A., Casali, Paolo G., Sommer, J., Stacchiotti, Silvia, Gronchi, Alesandro, Fossati, P., Akiyama, T., Alapetite, C., Baumann, M., Blay, Jean-Yves, Bolle, S., Boriani, S., Bruzzi, Paolo, Capanna, R., Caraceni, A., Casadei, R., Colia, V., Debus, Jürgen, Delaney, T., Dileo, P., Dijkstra, S., Doglietto, F., Flanagan, Adrienne, Froelich, S., Gardner, Paul A., Gelderblom, Hans, Gokaslan, Z. L., Haas, R. L., Heery, C., Hindi, Nadia, Hohenberger, Peter, Hornicek, F., Imai, R., Jeys, L., Jones, Robin L., Kasper, Bernd, Kawai, Akira, Krengli, M., Leithner, Andreas, Logowska, I., Martín-Broto, Javier, Mazzatenta, D., Morosi, Carlo, Nicolai, P., Norum, O. J., Patel, S., Penel, Nicolas, Picci, Piero, Pilotti, S., Radaelli, Stefano, Ricchini, F., Rutkowski, Piotr, Scheipl, S., Sen, C., Tamborini, E., Thornton, K. A., Timmermann, B., Torri, V., Tunn, P. U., Uhl, Matthias, Yamada, Y., Weber, D. C., Vanel, D., Varga, P. P., Vleggeert-Lankamp, C. L. A., Casali, Paolo G., and Sommer, J.
- Abstract
Chordomas are rare, malignant bone tumors of the skull-base and axial skeleton. Until recently, there was no consensus among experts regarding appropriate clinical management of chordoma, resulting in inconsistent care and suboptimal outcomes for many patients. To address this shortcoming, the European Society of Medical Oncology (ESMO) and the Chordoma Foundation, the global chordoma patient advocacy group, convened a multi-disciplinary group of chordoma specialists to define by consensus evidence-based best practices for the optimal approach to chordoma. In January 2015, the first recommendations of this group were published, covering the management of primary and metastatic chordomas. Additional evidence and further discussion were needed to develop recommendations about the management of local-regional failures. Thus, ESMO and CF convened a second consensus group meeting in November 2015 to address the treatment of locally relapsed chordoma. This meeting involved over 60 specialists from Europe, the United States and Japan with expertise in treatment of patients with chordoma. The consensus achieved during that meeting is the subject of the present publication and complements the recommendations of the first position paper.
- Published
- 2017
3. Best practices for the management of local-regional recurrent chordoma: a position paper by the chordoma global consensus group
- Author
-
Vittoria Colia, Bernd Kasper, R. Imai, Michael Baumann, Stéphanie Bolle, R. Capanna, Riccardo Casadei, Paolo G. Casali, Claire Alapetite, P. A. Gardner, C. L. A. Vleggeert-Lankamp, C. Heery, Elena Tamborini, Anant Desai, Stefano Radaelli, Alessandro Gronchi, Nadia Hindi, Akira Kawai, Daniel Vanel, C. Sen, Francesco Doglietto, Nicolas Penel, Ziya L. Gokaslan, S. Froelich, Katherine Anne Thornton, Carlo Morosi, Hans Gelderblom, Francis J. Hornicek, O. J. Norum, M. Uhl, Palma Dileo, Sandip Pravin Patel, Piero Fossati, J. Martin Broto, Peter Hohenberger, Rick L. Haas, Andreas Leithner, Toru Akiyama, F. Ricchini, Robin L. Jones, Valter Torri, Josh Sommer, Peter Pal Varga, Y. Yamada, Per-Ulf Tunn, J.-Y. Blay, Augusto Caraceni, Piotr Rutkowski, Jürgen Debus, Lee Jeys, Adrienne M. Flanagan, Diego Mazzatenta, I. Logowska, Marco Krengli, Damien C. Weber, Thomas F. DeLaney, Susanne Scheipl, P. Picci, Beate Timmermann, Piero Nicolai, S. Pilotti, P. Bruzzi, Silvia Stacchiotti, Stefano Boriani, S. Dijkstra, Fondazione IRCCS Istituto Nazionale Tumori - National Cancer Institute [Milan], European Institute of Oncology [Milan] (ESMO), Saitama University, Institut Curie [Paris], University of Dresden Medical School, Centre Léon Bérard [Lyon], Institut Gustave Roussy (IGR), University of Pisa - Università di Pisa, University Medical Center Heidelberg, Massachusetts General Hospital [Boston], Queen Elizabeth Hospital, University College London Hospitals (UCLH), Universiteit Leiden [Leiden], University of Brescia, Cancer Research UK London Research Institute, Hôpital Lariboisière, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Lariboisière-Fernand-Widal [APHP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Diderot - Paris 7 (UPD7), University of Pittsburgh School of Medicine, Pennsylvania Commonwealth System of Higher Education (PCSHE), Providence University, Netherlands Cancer Institute (NKI), Antoni van Leeuwenhoek Hospital, National Cancer Institute [Bethesda] (NCI-NIH), National Institutes of Health [Bethesda] (NIH), Hospital Universitario Virgen del Rocío [Sevilla], University of Heidelberg, Medical Faculty, Harvard Medical School [Boston] (HMS), Chiba University Hospital, Queens Elizabeth Hospital [Birmingham], Royal Marsden NHS Foundation Trust, National Cancer Center Research Institute [Tokyo], Università del Piemonte Orientale - Dipartimento DISIT Italy, Medical University Graz, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology (MCMCC), MD Anderson Cancer Center [Houston], The University of Texas Health Science Center at Houston (UTHealth), Evaluation des technologies de santé et des pratiques médicales - ULR 2694 (METRICS), Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), University Hospital Graz, New York University Langone Medical Center (NYU Langone Medical Center), NYU System (NYU), University of Duisbourg-Essen, Helios Klinikum [Erfurt], Memorial Sloane Kettering Cancer Center [New York], SwissFEL, Paul Scherrer Institut, Leiden University Medical Center (LUMC), Universiteit Leiden, CHU Lille, Université de Lille, METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694, European Institute of Oncology [Milan] [ESMO], Institut Gustave Roussy [IGR], University College London Hospitals [UCLH], Netherlands Cancer Institute [NKI], National Cancer Institute [Bethesda] [NCI-NIH], Harvard Medical School [Boston] [HMS], Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology [MCMCC], Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS], New York University Langone Medical Center [NYU Langone Medical Center], Leiden University Medical Center [LUMC], Stacchiotti, S., Gronchi, A., Fossati, P., Akiyama, T., Alapetite, C., Baumann, M., Blay, J. Y., Bolle, S., Boriani, S., Bruzzi, P., Capanna, R., Caraceni, A., Casadei, R., Colia, V., Debus, J., Delaney, T., Desai, A., Dileo, P., Dijkstra, S., Doglietto, F., Flanagan, A., Froelich, S., Gardner, P. A., Gelderblom, H., Gokaslan, Z. L., Haas, R., Heery, C., Hindi, N., Hohenberger, P., Hornicek, F., Imai, R., Jeys, L., Jones, R. L., Kasper, B., Kawai, A., Krengli, M., Leithner, A., Logowska, I., Martin Broto, J., Mazzatenta, D., Morosi, C., Nicolai, P., Norum, O. J., Patel, S., Penel, N., Picci, P., Pilotti, S., Radaelli, S., Ricchini, F., Rutkowski, P., Scheipl, S., Sen, C., Tamborini, E., Thornton, K. A., B., Timmermann, Torri, V., Tunn, P. U., Uhl, M., Yamada, Y., Weber, D. C., Vanel, D., Varga, P. P., Vleggeert-Lankamp, C. L. A., Casali, P. G., and Sommer, J.
- Subjects
sarcoma ,[SDV]Life Sciences [q-bio] ,Medizin ,chemotherapy ,Patient advocacy ,surgery ,0302 clinical medicine ,Neoplasm Recurrence ,Medicine ,chordoma ,relapse ,radiotherapy ,Relapse ,Sarcoma ,Hematology ,3. Good health ,Oncology ,030220 oncology & carcinogenesis ,Practice Guidelines as Topic ,chordoma, consensus, recurrence ,Sacral Chordoma ,musculoskeletal diseases ,medicine.medical_specialty ,recurrence ,Best practice ,MEDLINE ,Reviews ,610 Medicine & health ,03 medical and health sciences ,Chordoma ,Humans ,Chemotherapy ,Medical physics ,Radiotherapy ,business.industry ,medicine.disease ,Cervical spine ,consensus ,Family medicine ,Position paper ,Surgery ,Neoplasm Recurrence, Local ,business ,030217 neurology & neurosurgery - Abstract
Chordomas are rare, malignant bone tumors of the skull-base and axial skeleton. Until recently, there was no consensus among experts regarding appropriate clinical management of chordoma, resulting in inconsistent care and suboptimal outcomes for many patients. To address this shortcoming, the European Society of Medical Oncology (ESMO) and the Chordoma Foundation, the global chordoma patient advocacy group, convened a multi-disciplinary group of chordoma specialists to define by consensus evidence-based best practices for the optimal approach to chordoma. In January 2015, the first recommendations of this group were published, covering the management of primary and metastatic chordomas. Additional evidence and further discussion were needed to develop recommendations about the management of local-regional failures. Thus, ESMO and CF convened a second consensus group meeting in November 2015 to address the treatment of locally relapsed chordoma. This meeting involved over 60 specialists from Europe, the United States and Japan with expertise in treatment of patients with chordoma. The consensus achieved during that meeting is the subject of the present publication and complements the recommendations of the first position paper.
- Published
- 2017
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.